(EXX7) iShares Nikkei 225 (DE) - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE000A0H08D2 • Japan Large-Cap Equity
EXX7: Japanese, Stocks, Equities
The iShares Nikkei 225 UCITS ETF (DE), listed on XETRA under the ticker EXX7, is a Germany-domiciled exchange-traded fund designed to track the performance of the Morningstar Japan TME NR JPY Index. This ETF provides exposure to large-cap Japanese equities, making it a targeted tool for investors seeking to allocate to Japans prominent companies.
As a UCITS-compliant fund, it adheres to European investment regulations, ensuring transparency and liquidity for European investors. The ETF employs a replication strategy, meaning it holds the actual securities within the index it tracks, rather than using derivatives or sampling. This approach aligns closely with the underlying index, minimizing tracking error.
With an AUM of 28.25 billion EUR, this fund represents a sizable and liquid vehicle for accessing Japans equity market. The Morningstar Japan TME NR JPY Index focuses on large-cap companies, capturing the performance of Japans most established and globally significant firms. While the fund does not hedge currency exposure, this can be a double-edged sword: beneficial when the JPY strengthens against the EUR but detrimental in the opposite scenario.
Investors should note that the funds expense ratio and replication method are critical factors. The absence of P/E and other valuation metrics in the provided data underscores the importance of evaluating the underlying indexs fundamentals. For fund managers and investors, this ETF offers a straightforward way to diversify into Japanese large-caps, but its essential to assess currency risks and the broader economic context of Japan.
Additional Sources for EXX7 ETF
EXX7 ETF Overview
Market Cap in USD | 29,674m |
Category | Japan Large-Cap Equity |
IPO / Inception | 2006-07-05 |
EXX7 ETF Ratings
Growth 5y | 42.8% |
Fundamental | - |
Dividend | 38.6% |
Rel. Strength Industry | -16.7 |
Analysts | - |
Fair Price Momentum | 21.72 EUR |
Fair Price DCF | - |
EXX7 Dividends
Dividend Yield 12m | 0.98% |
Yield on Cost 5y | 1.35% |
Annual Growth 5y | 0.91% |
Payout Consistency | 91.2% |
EXX7 Growth Ratios
Growth Correlation 3m | 44.4% |
Growth Correlation 12m | 39.9% |
Growth Correlation 5y | 61% |
CAGR 5y | 7.20% |
CAGR/Max DD 5y | 0.29 |
Sharpe Ratio 12m | 0.22 |
Alpha | -14.93 |
Beta | 1.13 |
Volatility | 15.49% |
Current Volume | 2.5k |
Average Volume 20d | 4.8k |
As of February 22, 2025, the stock is trading at EUR 24.83 with a total of 2,491 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +2.73%, over three months by +5.41% and over the past year by +6.21%.
Partly, yes. Based on ValueRay Analyses, iShares Nikkei 225 (DE) (XETRA:EXX7) is currently (February 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 42.76 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXX7 as of February 2025 is 21.72. This means that EXX7 is currently overvalued and has a potential downside of -12.53%.
iShares Nikkei 225 (DE) has no consensus analysts rating.
According to ValueRays Forecast Model, EXX7 iShares Nikkei 225 (DE) will be worth about 26.1 in February 2026. The stock is currently trading at 24.83. This means that the stock has a potential upside of +4.99%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.1 | 5% |